Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Vaccines and Diagnostics Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IndividualfiledCriticalIndividual
Priority claimed from CA002145290Aexternal-prioritypatent/CA2145290C/en
Publication of CA2158427A1publicationCriticalpatent/CA2158427A1/en
Application grantedgrantedCritical
Publication of CA2158427CpublicationCriticalpatent/CA2158427C/en
Embodiments of the present invention feature methods and compositions for controlling the translation of viral peptides and proteins from viral nucleic acid, with particular applications to pestivirus and HCV. The methods and compositions feature control elements of the 5'UT region of the viral genome.
CA002158427A1992-09-281993-09-28Methods and compositions for controlling translation of hcv proteins
Expired - LifetimeCA2158427C
(en)
Novel polypeptide, dna coding for said polypeptide, recombinant vector containing said dna, recombinant virus prepared using said vector, and use thereof